Outcome Modifying Genes in Sickle Cell Disease

Institution(s): 
Duke University
Approx. Sample Size to be Sequenced: 
675

Project:

Disease/Phenotype: 

sickle cell disease

PI: 
Allison Ashley-Koch
Starting Phase: 
Phase 2
Phases Involved: 
2
Co-PI: 
Marilyn Telen
Sequencing Center Contact: 
Short Name: 
OMG_SCD
Sequencing Center(s) Phase 2: 
Baylor College of Medicine Human Genome Sequencing Center
Type of Sequencing: 
WGS
Sequencing External Funding: 
TOPMed Accession #: